Home › Calculator › INVA Dividend Calculator 2026
INVA Dividend DRIP Calculator 2026
9.37% YieldHealthcareInnoviva, Inc. · NASDAQ
Price: $21.34 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When INVA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your INVA snowball 📈
$10,000 in INVA → $6.72M in 10 years · $86.52/month
About Innoviva, Inc. (INVA) — Dividend Analysis 2026
Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates with Glaxo Group Limited under an agreement focused on the development and commercialization of daily LABA-based products designed to treat chronic obstructive pulmonary disease and asthma. Founded in 1996, the corporation was initially known as Theravance, Inc., before officially changing its name to Innoviva, Inc. in January 2016. Its primary operational base is situated in Burlingame, California.
Compare INVA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full INVA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open INVA position with:
🌍 INVA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold INVA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 9.37% | 6.57% | $937 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 7.96% | 5.16% | $796 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 7.50% | 4.70% | $750 / yr |
| 🇬🇧 UK ISA | 0% | 9.37% | 6.57% | $937 / yr |
| 🇬🇧 UK Taxable | 8.75% | 8.55% | 5.75% | $855 / yr |
| 🇨🇦 TFSA | 0% | 9.37% | 6.57% | $937 / yr |
| 🇨🇦 CA Taxable | 25% | 7.03% | 4.23% | $703 / yr |
| 🇦🇺 Super (pension) | 15% | 7.96% | 5.16% | $796 / yr |
| 🇦🇺 AU Taxable | 30% | 6.56% | 3.76% | $656 / yr |
| 🇩🇪 DE Taxable | 26.375% | 6.90% | 4.10% | $690 / yr |
| 🇫🇷 FR Taxable | 30% | 6.56% | 3.76% | $656 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 INVA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 INVA Dividend Payment Schedule
INVA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 INVA vs Healthcare Benchmarks
How INVA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for INVA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ INVA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-08-20 | 1,127 | $21.00 | $23.7K | ||
| F-InKind | 2026-08-20 | 558 | $21.00 | $11.7K | ||
| F-InKind | 2026-08-20 | 1,130 | $21.00 | $23.7K | ||
| A-Award | 2026-05-15 | 1,123 | — | — | ||
| F-InKind | 2026-05-20 | 559 | $22.24 | $12.4K | ||
| A-Award | 2026-05-15 | 1,123 | — | — | ||
| F-InKind | 2026-05-20 | 1,130 | $22.24 | $25.1K | ||
| F-InKind | 2026-05-20 | 1,127 | $22.24 | $25.1K | ||
| A-Award | 2026-05-18 | 9,461 | — | — | ||
| A-Award | 2026-05-18 | 9,166 | $21.80 | $199.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the INVA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Innoviva, Inc. (INVA) is currently trading at $21.34, 9% below its 52-week high. The current dividend yield is 9.37% based on an annual payout of $2.00 per share.
INVA (Innoviva, Inc.) — 9.37% Dividend Yield Analysis
Innoviva, Inc. (INVA) is a healthcare stock currently trading at $21.34 with a dividend yield of 9.37%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (9.37%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest INVA News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.